This brand name is authorized in Ireland, Malta
The drug FOZNOL contains one active pharmaceutical ingredient (API):
|
1
Lanthanum carbonate hydrate
UNII 490D9F069T - LANTHANUM CARBONATE
|
|
Lanthanum is indicated as a phosphate binding agent for use in the control of hyperphosphataemia. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| V03AE03 | Lanthanum carbonate | V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AE Drugs for treatment of hyperkalemia and hyperphosphatemia |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: MT | Medicines Authority | Identifier(s): MA1464/00101, MA1464/00102, MA1464/00103, MA1464/00104 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
